2025-11-11 Sale AxoGen, Inc. AXGN
director $24.02 $86,249 +52.78% 2025-11-10 Sale AxoGen, Inc. AXGN
director $24.01 $461,640 +55.42% 2025-11-06 Sale AxoGen, Inc. AXGN
director $24.01 $128,371 +55.17% 2025-11-05 Sale AxoGen, Inc. AXGN
director $24.05 $274,893 +59.2% 2025-10-30 Sale AxoGen, Inc. AXGN
director $23.00 $419,704 +61.73% 2025-10-29 Sale AxoGen, Inc. AXGN
director $20.55 $827,013 +63.96% 2025-10-06 Sale AxoGen, Inc. AXGN
director $18.00 $13,249 +104.02% 2025-10-03 Sale AxoGen, Inc. AXGN
director $18.21 $403,650 +95.13% 2025-10-02 Sale AxoGen, Inc. AXGN
director $18.01 $180,424 +94.91% 2025-06-09 Sale AxoGen, Inc. AXGN
director $10.61 $43,215 +180.69% 2023-08-23 Purchase AxoGen, Inc. AXGN
director $6.56 $65,600 +9.66% 2021-08-23 Sale Haemonetics Corporation HAE
EVP, Chief Financial Officer $60.51 $1.37M -1.45% 2021-07-01 Sale Haemonetics Corporation HAE
EVP, Chief Financial Officer $66.60 $285,914 -12.47% 2021-06-14 Sale Haemonetics Corporation HAE
EVP, Chief Financial Officer $59.87 $11,375 -0.92% 2021-06-07 Sale Haemonetics Corporation HAE
EVP, Chief Financial Officer $55.09 $22,642 +4.66% 2021-05-19 Sale Haemonetics Corporation HAE
EVP, Chief Financial Officer $55.19 $13,135 +3.26% 2021-05-17 Sale Haemonetics Corporation HAE
EVP, Chief Financial Officer $55.97 $12,257 +2.09% 2020-10-26 Sale Haemonetics Corporation HAE
EVP, Chief Financial Officer $106.00 $123,066 -33.64% 2020-06-16 Sale Haemonetics Corporation HAE
EVP, Chief Financial Officer $91.02 $1.15M +5.01% 2020-06-15 Sale Haemonetics Corporation HAE
EVP, Chief Financial Officer $87.71 $852,541 +6.12%